An informa business www.citeline.com SLA Pipeline Town Hall Meeting Christine Blazynski PhD Sr. Vice-President Product Development
Mar 27, 2015
An informa business www.citeline.com
SLA Pipeline Town Hall Meeting
Christine Blazynski PhDSr. Vice-President
Product Development
An informa business www.citeline.com
TrialTroveClinical Trials Intelligence
Integrated and Enterprise-Wide ServicesPipeline / Pharmaprojects
Drug Intelligence
All Drugs InDevelopmentFrom BenchTo Market
TrialPredictTrials Timing / Benchmarking
Citeline Proprietary
Prediction of Trials Enrollment
Timing
World’s foremost collection
of
clinical trials,investigators, sites,
drugs & analysis
Global Coverage
Of Clinical Trials Design and Status
SiteTroveInvestigator / Site Selection
Investigators And Sites
Based UponDirect TrialsExperience
Citeline AnalyticsMapping the Competition
Map Date:
6/23/07 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
Adjuvant
Phase II Biomarker/Tox
Phase III Biomarker/SE, PGX
EI, Biomarker/SE, PGX
Neoadjuvant
Phase II Biomarker/SE
PGX
Biomarker/SE
Biomarker/SE
Biomarker/SE
PGX
Biomarker/SE
Biomarker/SE
Phase III Biomarker/SE, PGX
PGX
NeoAdjuvant and Adjuvant
Phase II Biomarker/Tox
2010 2011
Competitive Development Map
20142012 201320052004
Drug: Tykerb (Lapatinib)Disease: Breast CancerAdjuvant and Neoadjuvant Therapy
2006 2007 2008 2009
Lap +Tras (+ AC,Doxo,Pac,Surg), 0/I/II/III, TA100, #70768
Lap, I/II/III, TA150, #52438
Lap, I/II/III, TA120, #45628
Lap (+ AC,Doc,Doxo), II/III, TA71, #60281
Lap (+/vs Tras, + Chemo), II/III, TA120, #63895
Lap (+/vs Tras, + Pac), I/II, TA450, NEO-ALTTO, (#53035)
Lap (+/vs Tras, +AC,Doxo), II/III, TA522, #71240
Lap (+/vs Let), II/III, TA91, #63171
Lap, II/III, #51923
Lap, II/III/IV, TA22-55, #33321
Lap (+ AC,Doxo,Pac,Tras), 0/I/II/III, TA109, #65110
Lap (4-arm trial), I/II, TA8000, ALTTO, (#45399)
Lap, I/II/III, TA3000, TEACH, (#56312)
Lap (+/vs Tras, + AC,Doxo), I/II, #55823
Lap (+ Pac,Surg), III/IV, AA50/TA60, #29064
Lap (+ Ab), I/II/III, TA30, #50405
Visualization ofClinical
DevelopmentPrograms
An informa business www.citeline.com
Depth and Breadth of Citeline Data
150 countries covered 180+ disease areas in TrialTrove/ >1000 in Pipeline
☐ 222 therapeutic categories in Pipeline 250+ analysts and editors 18,000 data sources >4,000 companies developing therapeutics >46,000 drugs
☐ Over 30 years of history >120,000 interventional trials >250,000 investigator profiles
An informa business www.citeline.com
Citeline’s Drug Intelligence
One centralized database of drug information
Deep integration with Citeline’s clinical development offerings
An informa business www.citeline.com
Pharmaprojects
Legacy pipeline database☐ PJB publications
Thirty-one continual years of tracking drug development☐ Print 3rd party electronic distributer CD ROM Web
delivery☐ Updated once weekly
Trends data from 1995 through 2010
An informa business www.citeline.com
Pipeline
Continually updated/real-time
Clean, simple, user-friendly interface
Customized alerts, saved searches, and share search
Unlimited research support
Search criteria expanded over time
All fields export or disease-focused export
Integration with TrialTrove, SiteTrove and TrialPredict
An informa business www.citeline.com
Export Options
An informa business www.citeline.com
An informa business www.citeline.com
Recent Enhancements
☐ Hierarchical mechanism search
☐ Addition of biosimilars/biogenerics
☐ Company country HQ search and research focus
☐ Delivery route/medium/technology search
☐ Advanced search [phase 1]
☐ Automatic search for trials from multiple drug results
☐ Search by latest change date or range
An informa business www.citeline.com
Pipeline
An informa business www.citeline.com
Planned Enhancements
☐ Advanced Search: nested booleans, ability to move search terms, edit operators within and between categories
☐ NCE search
☐ Search by chemical name
☐ Search by originator OR licensee
☐ Trial reporting: tabular view
☐ Dashboard reporting
An informa business www.citeline.com
An informa business www.citeline.com
Citeline’s Drug Intelligence
One centralized database of drug information
Drug, company data to meet all business development needs
An informa business www.citeline.com
Citeline - MedTrack MedTrack joined Citeline in late March 2011. As of April 6:
☐ 21,326 companies☐ 107,199 drugs (not all unique; includes generics)☐ 1,556 drug delivery technologies☐ 55,758 deals☐ 642 indications☐ 615,114 searchable news releases☐ 142,525 management bios☐ 481,558 searchable SEC documents
MedTrack V2 migration continues Planning for initial integration between products just starting but clear
synergies exist Need for market research and focus groups……… will you help?